Welcome to our dedicated page for Dupont De Nemours SEC filings (Ticker: DD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The DuPont de Nemours, Inc. (NYSE: DD) SEC filings page provides access to the company’s official disclosures filed with the U.S. Securities and Exchange Commission. These documents include current reports on Form 8-K, annual and quarterly reports when available, and exhibits that describe material agreements, capital structure changes and significant portfolio transactions.
DuPont’s recent 8-K filings illustrate how its SEC documents can inform investors about major corporate events. In 2025, DuPont filed multiple 8-Ks detailing the separation of its electronics business into Qnity Electronics, Inc., including the Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement, Intellectual Property Cross-License Agreement, Transition Services Agreements and a Legacy Liabilities Assignment Agreement. Another 8-K furnishes unaudited pro forma consolidated financial information reflecting DuPont’s post-separation structure.
Filings also describe the planned divestiture of DuPont’s aramids business, including Kevlar and Nomex, through a Transaction Agreement with entities affiliated with Arclin. Additional 8-Ks outline DuPont’s debt and capital markets activities, such as exchange offers for senior notes, supplemental indentures, issuance of new notes, special mandatory redemption provisions, consent solicitations and tender offers for portions of its long-dated notes. These documents provide detailed terms of DuPont’s obligations and capital structure adjustments.
Investors can review DuPont’s 8-K dated November 6, 2025 for quarterly financial results and segment information, including the IndustrialsCo and ElectronicsCo segments prior to the Qnity separation. Other filings report on board and executive changes, as well as the determination of percentages used to calculate Minimum EBITDA thresholds under legacy agreements following the Qnity spin-off.
On Stock Titan, DuPont filings are updated as they are released to EDGAR, and AI-powered summaries can help explain the key points in complex documents such as transaction agreements, supplemental indentures and pro forma financial statements. Users can use this page to locate DuPont’s 10-K and 10-Q reports when filed, as well as Form 8-K disclosures that highlight material events, enabling a deeper understanding of the company’s evolving portfolio, governance and financial commitments.
DuPont de Nemours, Inc. director Edward D. Breen reported a routine tax-withholding transaction related to equity compensation. On May 4, 2026, 11,538.1584 shares of Common Stock were disposed of to cover taxes on lapsed RSUs and associated dividend equivalent units. This was not an open-market sale. After this withholding, Breen directly holds 273,977.876 shares of DuPont common stock, including shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. SVP & CFO Antonella B. Franzen reported a routine tax-withholding share disposition related to vesting equity awards. On this event, 245.8361 shares of common stock were withheld at $45.54 per share to cover taxes on lapsed RSUs and associated dividend equivalent units, rather than sold on the open market. After this withholding, she directly holds 70,366.7801 shares of DuPont common stock, including shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. senior vice president and general counsel Erik T. Hoover reported a routine tax-related share disposition. On May 4, 2026, 1,525.6839 shares of common stock were withheld at $45.5400 per share to cover taxes on lapsed RSUs and associated dividend equivalent units. Following this withholding and including shares acquired through dividend reinvestment, Hoover directly holds 115,971.9470 shares of DuPont common stock.
DuPont de Nemours, Inc. CEO Lori Koch reported a tax-withholding disposition of 3,048.3678 shares of Common Stock at $45.54 per share. The shares were withheld on May 4, 2026 to cover taxes on lapsed RSUs and related dividend equivalent units, rather than sold in the open market.
After this withholding, Koch directly holds 349,844.5631 shares of DuPont Common Stock, which includes shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. Senior Vice President & CHRO Christopher Raia reported a tax-related share disposition. On lapsed RSUs and related dividend equivalent units, 1,270.3893 common shares were withheld at $45.54 per share to cover tax obligations, rather than sold on the open market.
After this withholding, Raia directly holds 85,911.2563 DuPont common shares, which includes shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. reports higher profitability for the quarter ended March 31, 2026 while continuing a major portfolio reshaping. Net sales from continuing operations rose to $1.681 billion from $1.612 billion, and income from continuing operations increased to $150 million from $80 million.
Including discontinued operations, net income was $164 million, compared with a net loss of $(581) million a year earlier that was driven by large Aramids goodwill impairment and separation-related charges. Discontinued operations contributed $14 million of income versus a $(661) million loss in 2025.
On April 1, 2026 DuPont closed the Aramids business divestiture for gross consideration of $1.8 billion, receiving about $1.2 billion in cash, a $300 million note and a non‑controlling equity stake valued at $325 million. The Aramids and prior Electronics businesses are reported as discontinued operations. DuPont also launched a $80 million restructuring program in 2026 and is seeking shareholder approval for a reverse stock split at a 1‑for‑2 to 1‑for‑4 ratio, with a corresponding reduction in authorized shares. Environmental and PFAS‑related indemnification liabilities and reserves remain significant but are subject to cost‑sharing arrangements and proposed long‑term settlements.
DuPont de Nemours reported solid first quarter 2026 results and raised its full-year 2026 outlook. Net sales reached $1.681 billion, up 4% with 2% organic growth, while operating EBITDA rose to $414 million, a 15% increase and a 230 basis point margin expansion to 24.6%.
GAAP income from continuing operations grew to $150 million and GAAP EPS to $0.36, with adjusted EPS rising to $0.55, up 53% from the prior year. Cash provided by operating activities from continuing operations improved to $232 million, supporting transaction-adjusted free cash flow of $147 million.
The Healthcare & Water Technologies segment delivered 6% higher net sales and a 30.3% operating EBITDA margin; Diversified Industrials grew sales 3% with margins up to 22.9%. DuPont completed the $1.2 billion cash sale of its Aramids business plus a $300 million note and $325 million equity stake, and announced a planned $275 million accelerated share repurchase. The company now guides 2026 net sales of $7.155–$7.215 billion, operating EBITDA of $1.73–$1.76 billion, and adjusted EPS of $2.35–$2.40.
DuPont de Nemours Inc reported institutional ownership disclosure by Vanguard Capital Management. Vanguard Capital Management reports beneficial ownership of 30,793,971 shares of Common Stock, representing 7.51% of the class. The filing shows sole voting power of 4,200,077 shares and sole dispositive power of 30,793,971 shares.
DuPont de Nemours, Inc. reported that Luke Kissam resigned from its Board of Directors effective April 14, 2026. He is leaving in connection with his future appointment as Chief Executive Officer of Corteva, Inc. The company stated his departure is not due to any disagreement over operations, policies, or practices. Following his resignation, DuPont’s Board size was reduced from eleven to ten directors.